187 related articles for article (PubMed ID: 17152926)
21. In vitro interactions between sitamaquine and amphotericin B, sodium stibogluconate, miltefosine, paromomycin and pentamidine against Leishmania donovani.
Seifert K; Munday J; Syeda T; Croft SL
J Antimicrob Chemother; 2011 Apr; 66(4):850-4. PubMed ID: 21393188
[TBL] [Abstract][Full Text] [Related]
22. Heparin enhances the interaction of infective Leishmania donovani promastigotes with mouse peritoneal macrophages. A fluorescence flow cytometric analysis.
Butcher BA; Sklar LA; Seamer LC; Glew RH
J Immunol; 1992 May; 148(9):2879-86. PubMed ID: 1573275
[TBL] [Abstract][Full Text] [Related]
23. Edelfosine induces an apoptotic process in Leishmania infantum that is regulated by the ectopic expression of Bcl-XL and Hrk.
Alzate JF; Arias A; Mollinedo F; Rico E; de la Iglesia-Vicente J; Jiménez-Ruiz A
Antimicrob Agents Chemother; 2008 Oct; 52(10):3779-82. PubMed ID: 18644968
[TBL] [Abstract][Full Text] [Related]
24. Mitochondria and lipid raft-located FOF1-ATP synthase as major therapeutic targets in the antileishmanial and anticancer activities of ether lipid edelfosine.
Villa-Pulgarín JA; Gajate C; Botet J; Jimenez A; Justies N; Varela-M RE; Cuesta-Marbán Á; Müller I; Modolell M; Revuelta JL; Mollinedo F
PLoS Negl Trop Dis; 2017 Aug; 11(8):e0005805. PubMed ID: 28829771
[TBL] [Abstract][Full Text] [Related]
25. In vitro and in vivo interactions between miltefosine and other antileishmanial drugs.
Seifert K; Croft SL
Antimicrob Agents Chemother; 2006 Jan; 50(1):73-9. PubMed ID: 16377670
[TBL] [Abstract][Full Text] [Related]
26. Lipase Precursor-Like Protein Promotes Miltefosine Tolerance in Leishmania donovani by Enhancing Parasite Infectivity and Eliciting Anti-inflammatory Responses in Host Macrophages.
Deep DK; Singh R; Kulshrestha A; Wajid S; Salotra P
Antimicrob Agents Chemother; 2018 Dec; 62(12):. PubMed ID: 30297367
[TBL] [Abstract][Full Text] [Related]
27. Characterisation of Leishmania donovani promastigotes resistant to hexadecylphosphocholine (miltefosine).
Seifert K; Matu S; Javier Pérez-Victoria F; Castanys S; Gamarro F; Croft SL
Int J Antimicrob Agents; 2003 Oct; 22(4):380-7. PubMed ID: 14522101
[TBL] [Abstract][Full Text] [Related]
28. Intracellular infection by Leishmania donovani inhibits macrophage apoptosis.
Moore KJ; Matlashewski G
J Immunol; 1994 Mar; 152(6):2930-7. PubMed ID: 8144893
[TBL] [Abstract][Full Text] [Related]
29. Selection and phenotype characterisation of sitamaquine-resistant promastigotes of Leishmania donovani.
Bories C; Cojean S; Huteau F; Loiseau PM
Biomed Pharmacother; 2008 Mar; 62(3):164-7. PubMed ID: 18249083
[TBL] [Abstract][Full Text] [Related]
30. Miltefosine induces apoptosis-like death in Leishmania donovani promastigotes.
Paris C; Loiseau PM; Bories C; Bréard J
Antimicrob Agents Chemother; 2004 Mar; 48(3):852-9. PubMed ID: 14982775
[TBL] [Abstract][Full Text] [Related]
31. Leishmania donovani mitochondrial iron superoxide dismutase A is released into the cytosol during miltefosine induced programmed cell death.
Getachew F; Gedamu L
Mol Biochem Parasitol; 2012 May; 183(1):42-51. PubMed ID: 22342963
[TBL] [Abstract][Full Text] [Related]
32. In vitro 4-Aryloxy-7-chloroquinoline derivatives are effective in mono- and combined therapy against Leishmania donovani and induce mitocondrial membrane potential disruption.
Valdivieso E; Mejías F; Torrealba C; Benaim G; Kouznetsov VV; Sojo F; Rojas-Ruiz FA; Arvelo F; Dagger F
Acta Trop; 2018 Jul; 183():36-42. PubMed ID: 29604246
[TBL] [Abstract][Full Text] [Related]
33. Sinefungin and taxol effects on cell cycle and cytoskeleton of Leishmania donovani promastigotes.
Moulay L; Robert-Gero M; Brown S; Gendron MC; Tournier F
Exp Cell Res; 1996 Aug; 226(2):283-91. PubMed ID: 8806432
[TBL] [Abstract][Full Text] [Related]
34. Miltefosine affects lipid metabolism in Leishmania donovani promastigotes.
Rakotomanga M; Blanc S; Gaudin K; Chaminade P; Loiseau PM
Antimicrob Agents Chemother; 2007 Apr; 51(4):1425-30. PubMed ID: 17242145
[TBL] [Abstract][Full Text] [Related]
35. Interleukin 1alpha activity of peritoneal and bone marrow macrophages infected with Leishmania major and Leishmania donovani in vitro.
Bersudsky M; Apte RN; El-On J
Exp Parasitol; 2000 Mar; 94(3):150-7. PubMed ID: 10831379
[TBL] [Abstract][Full Text] [Related]
36. Potential of doxorubicin as an antileishmanial agent.
Sett R; Basu N; Ghosh AK; Das PK
J Parasitol; 1992 Apr; 78(2):350-4. PubMed ID: 1556650
[TBL] [Abstract][Full Text] [Related]
37. Novobiocin induces apoptosis-like cell death in topoisomerase II over-expressing arsenite resistant Leishmania donovani.
Singh G; Jayanarayan KG; Dey CS
Mol Biochem Parasitol; 2005 May; 141(1):57-69. PubMed ID: 15811527
[TBL] [Abstract][Full Text] [Related]
38. Antileishmanial activity of the ether phospholipid ilmofosine.
Croft SL; Neal RA; Thornton EA; Herrmann DB
Trans R Soc Trop Med Hyg; 1993; 87(2):217-9. PubMed ID: 8337733
[TBL] [Abstract][Full Text] [Related]
39. Transgenic Leishmania donovani clinical isolates expressing green fluorescent protein constitutively for rapid and reliable ex vivo drug screening.
Singh N; Gupta R; Jaiswal AK; Sundar S; Dube A
J Antimicrob Chemother; 2009 Aug; 64(2):370-4. PubMed ID: 19525291
[TBL] [Abstract][Full Text] [Related]
40. Leishmania donovani: a glycosyl dihydropyridine analogue induces apoptosis like cell death via targeting pteridine reductase 1 in promastigotes.
Kaur J; Singh BK; Tripathi RP; Singh P; Singh N
Exp Parasitol; 2009 Nov; 123(3):258-64. PubMed ID: 19647734
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
